Evidence map›Paper›PMID 41280063›Full record

ArticlebioRxiv : the preprint server for biology2025

Encoded cell-material interactions to reroute cytokine signaling for regenerative medicine.

Zachary M Eidman, Jhanvi Sharma, Joanne C Lee, Nicholas F Schulze, Hannah J Brien, Kevin C Corn, Marjan Rafat, Jonathan M Brunger

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Zachary M EidmanDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN.
Jhanvi SharmaDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN.
Joanne C LeeDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN.
Nicholas F SchulzeDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN.
Hannah J BrienDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN.
Kevin C CornDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN.
Marjan RafatDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN.
Jonathan M BrungerDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN.ORCID 0000-0001-7468-7982

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ben Ho Park · 1995 to 2026
$172.8M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MARY Kay WASHINGTON · 2002 to 2026
$29.9M
Integrated Training in Engineering and DiabetesT32DK101003 · NIDDK · VANDERBILT UNIVERSITY · PI Jamey D. Young · 2014 to 2026
$3.9M
Engineered cells as agents of arthritis therapy governed by artificial signalingR01AR083437 · NIAMS · VANDERBILT UNIVERSITY · PI Jonathan Matthew Brunger · 2024 to 2026
$1.2M
NCI NIH HHS P30 CA068485NIAMS NIH HHS R01 AR083437NIDDK NIH HHS P30 DK058404NIDDK NIH HHS T32 DK101003
6 · The paper itself

Abstract

Regenerative engineering harnesses materials science and stem cell biology to develop strategies to repair damaged and diseased tissue. Despite advances in designer materials, few techniques effectively provide auto-regulated feedback mechanisms that govern how cells sense and respond to discrete microenvironmental changes. Here, we demonstrate that the artificial, juxtacrine-like receptor synthetic Notch (synNotch) can be activated by endogenous multimeric cytokines in solution, without immobilizing materials, revealing a previously unreported activation modality and yielding up to 24-fold dynamic range. To broaden synNotch sensing to monomeric cytokines, we developed nMATRIX, a co-engineered material-cell platform that detects endogenous, soluble ligands and routes them to programmed gene circuits with spatially confined effects. nMATRIX can be tuned to recognize the interleukins IL-1β and IL-6 using synNotch receptors plus cognate biomaterials, yielding up to 68-fold dynamic range and converting these inflammatory inputs into orthogonal outputs that reprogram nearby cell phenotypes. nMATRIX functions across multiple cell types and can incorporate the synNotch-related SNIPR synthetic receptor platform. nMATRIX repurposed inflammatory signals and converted them into anti-inflammatory cues to polarize macrophages (increased CD163, CD206; decreased CD86). Thus, nMATRIX couples native soluble cues to customized cellular responses with tunable sensitivity, offering a flexible materials-based approach for self-regulating regenerative therapies.

Identifiers

PMID41280063
PMCPMC12633323

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.